JAC Advance Access published online on July 26, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki266
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Healthcare-Associated Infection and Antimicrobial Resistance, Communicable Disease Surveillance Centre, HPA Centre for Infections, Colindale, London NW9 5EQ, UK
* To whom correspondence should be addressed. Surveillance of bacteraemia caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK has involved collection of data from hospital microbiology laboratories via several mechanisms, including a voluntary reporting scheme that has been operational in England and Wales since 1989 and mandatory reporting schemes that have been running independently in England, Wales, Scotland and Northern Ireland since 2001. In addition, surveillance schemes involving panels of participating sentinel laboratories that submit isolates for centralized susceptibility testing, such as the Bacteraemia Resistance Surveillance Programme run by the BSAC, have also been established. Each of these data sources have particular advantages, but they also have their individual limitations, with the result that they each give an incomplete picture if considered in isolation. However, by pooling the findings from these different but complementary surveillance programmes, a much more comprehensive and credible picture of the problem posed by MRSA is produced. These schemes have shown both a dramatic rise in the total numbers of cases of S. aureus bacteraemia reported annually and an increase in the proportion of such cases that involve MRSA (from 2% in 1990 to >40% in the early 2000s), although the most recent data indicate a slight reversal of these trends. Characterization of isolates of MRSA shows a marked temporal relationship between the rise in MRSA bacteraemias and the emergence and spread of two strains of epidemic MRSA, EMRSA-15 and EMRSA-16. Surveillance and control of MRSA infection continue to be high profile and further developments to the mandatory surveillance system in England are likely in the near future.
Review
Surveillance and epidemiology of MRSA bacteraemia in the UK
Alan P. Johnson, E-mail: alan.johnson{at}hpa.org.uk
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Pearson, A. Chronias, and M. Murray Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England J. Antimicrob. Chemother., September 1, 2009; 64(suppl_1): i11 - i17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. McNulty Reducing urinary catheter related infections in care homes: a review of the literature Journal of Infection Prevention, March 1, 2009; 10(2): 70 - 75. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Livermore and M. Warner Effects of low temperature and high salt on the activity of the novel carbapenem PZ-601 (SMP-601) against methicillin-resistant Staphylococcus aureus J. Antimicrob. Chemother., February 1, 2009; 63(2): 411 - 413. [Full Text] [PDF]
|
|
|
|
|
|
R. Hope, D. M. Livermore, G. Brick, M. Lillie, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06 J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii65 - ii74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Aldeyab, D. L. Monnet, J. M. Lopez-Lozano, C. M. Hughes, M. G. Scott, M. P. Kearney, F. A. Magee, and J. C. McElnay Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis J. Antimicrob. Chemother., September 1, 2008; 62(3): 593 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aires-de-Sousa, B. Correia, H. de Lencastre, and and the Multilaboratory Project Collaborators Changing Patterns in Frequency of Recovery of Five Methicillin-Resistant Staphylococcus aureus Clones in Portuguese Hospitals: Surveillance over a 16-Year Period J. Clin. Microbiol., September 1, 2008; 46(9): 2912 - 2917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Larsen, R. L. Skov, V. Jarlier, and A. S. Henriksen Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections J. Antimicrob. Chemother., March 1, 2008; 61(3): 589 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reinert, D. E. Low, F. Rossi, X. Zhang, C. Wattal, and M. J. Dowzicky Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline J. Antimicrob. Chemother., November 1, 2007; 60(5): 1018 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Matthews, C. P. Conlon, A. R. Berendt, J. Kayley, L. Jefferies, B. L. Atkins, and I. Byren Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years J. Antimicrob. Chemother., August 1, 2007; 60(2): 356 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Milheirico, D. C. Oliveira, and H. de Lencastre Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: 'SCCmec IV multiplex' J. Antimicrob. Chemother., July 1, 2007; 60(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tunney, C. Hughes, and J. Magee Infection control policies and procedures for meticillin-resistant Staphylococcus aureus in care homes for older people in Northern Ireland: a questionnaire study Journal of Infection Prevention, December 1, 2006; 7(6): 20 - 24. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Cassat, P. M. Dunman, E. Murphy, S. J. Projan, K. E. Beenken, K. J. Palm, S.-J. Yang, K. C. Rice, K. W. Bayles, and M. S. Smeltzer Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology, October 1, 2006; 152(Pt 10): 3075 - 3090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Brady, R. Loughlin, D. Gilpin, P. Kearney, and M. Tunney In vitro activity of tea-tree oil against clinical skin isolates of meticillin-resistant and -sensitive Staphylococcus aureus and coagulase-negative staphylococci growing planktonically and as biofilms. J. Med. Microbiol., October 1, 2006; 55(Pt 10): 1375 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Jury, M. Al-Mahrous, M. Apostolou, S. Sandiford, A. Fox, W. Ollier, and M. Upton Rapid cost-effective subtyping of meticillin-resistant Staphylococcus aureus by denaturing HPLC. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1053 - 1060. [Abstract] [Full Text] [PDF]
|
|